ROIV 株価推移チャート
ROIV 株価予測
Roivant Sciences Ltd
$29.83
2.19%
$0.63
終値： Apr 17, 16:00:00 GMT-4
$29.8
-0.1%
$-0.02
アフターマーケット：Apr 17, 20:00:00 GMT-4
戻る
Roivant Sciences Ltd (ROIV) 株価予測
主要データ
前終値
$29.19
始値
$29.56
当日レンジ
$29 - $30.18
52週レンジ
$9.87 - $30.33
取引高
6.0M
平均取引高
6.0M
配当利回り
--
1株当たり利益(TTM)
-1.17
時価総額
$21.3B
ROIVとは何ですか？
Roivant Sciences Ltd. engages in the biopharmaceutical business, which engages in the development of transformative medicine. The Company’s pipeline includes brepocitinib, a potent small molecule inhibitor of TYK2 and JAK1 in development for the treatment of dermatomyositis, non-infectious uveitis and cutaneous sarcoidosis; IMVT-1402 and batoclimab, fully human monoclonal antibodies targeting FcRn in development across several IgG-mediated autoimmune indications; and mosliciguat, an inhaled sGC activator in development for pulmonary hypertension associated with interstitial lung disease. The company also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business.